688137 近岸蛋白
已收盘 07-09 15:00:01
资讯
新帖
简况
每周股票复盘:近岸蛋白(688137)加码前沿研发平台建设
证券之星 · 07-05
每周股票复盘:近岸蛋白(688137)加码前沿研发平台建设
股市必读:近岸蛋白(688137)6月30日披露最新机构调研信息
证券之星 · 07-01
股市必读:近岸蛋白(688137)6月30日披露最新机构调研信息
每周股票复盘:近岸蛋白(688137)完成股份回购并注销25.8万股
证券之星 · 06-28
每周股票复盘:近岸蛋白(688137)完成股份回购并注销25.8万股
近岸蛋白(688137)披露股份回购实施结果暨股份变动公告,6月23日股价上涨4.13%
证券之星 · 06-23
近岸蛋白(688137)披露股份回购实施结果暨股份变动公告,6月23日股价上涨4.13%
近岸蛋白(688137)披露2025年年度股东会决议公告,5月25日股价下跌3.39%
证券之星 · 05-25
近岸蛋白(688137)披露2025年年度股东会决议公告,5月25日股价下跌3.39%
每周股票复盘:近岸蛋白(688137)2025年年度股东会顺利召开
证券之星 · 05-24
每周股票复盘:近岸蛋白(688137)2025年年度股东会顺利召开
每周股票复盘:近岸蛋白(688137)2025年营收1.46亿元
证券之星 · 05-17
每周股票复盘:近岸蛋白(688137)2025年营收1.46亿元
5月15日近岸蛋白跌5.11%,国联医疗健康混合A基金重仓该股
证券之星 · 05-15
5月15日近岸蛋白跌5.11%,国联医疗健康混合A基金重仓该股
近岸蛋白(688137)披露2025年年度股东会会议资料,5月14日股价下跌0.78%
证券之星 · 05-14
近岸蛋白(688137)披露2025年年度股东会会议资料,5月14日股价下跌0.78%
每周股票复盘:近岸蛋白(688137)拟注销25.8万股回购股份
证券之星 · 05-10
每周股票复盘:近岸蛋白(688137)拟注销25.8万股回购股份
近岸蛋白(688137)披露关于注销部分回购股份、减少注册资本及修订《公司章程》的议案,5月8日股价下跌1.98%
证券之星 · 05-08
近岸蛋白(688137)披露关于注销部分回购股份、减少注册资本及修订《公司章程》的议案,5月8日股价下跌1.98%
5月7日近岸蛋白涨5.66%,国联医疗健康混合A基金重仓该股
证券之星 · 05-07
5月7日近岸蛋白涨5.66%,国联医疗健康混合A基金重仓该股
每周股票复盘:近岸蛋白(688137)股东户数增31.06%,一季度营收增11.37%
证券之星 · 05-02
每周股票复盘:近岸蛋白(688137)股东户数增31.06%,一季度营收增11.37%
近岸蛋白(688137)3月31日股东户数0.67万户,较上期增加31.06%
证券之星 · 04-29
近岸蛋白(688137)3月31日股东户数0.67万户,较上期增加31.06%
图解近岸蛋白年报:第四季度单季净利润同比下降35.31%
证券之星 · 04-29
图解近岸蛋白年报:第四季度单季净利润同比下降35.31%
近岸蛋白(688137)披露拟注销已回购股份暨减少注册资本公告,4月27日股价上涨1.58%
证券之星 · 04-27
近岸蛋白(688137)披露拟注销已回购股份暨减少注册资本公告,4月27日股价上涨1.58%
每周股票复盘:近岸蛋白(688137)变更持续督导保荐代表人
证券之星 · 04-26
每周股票复盘:近岸蛋白(688137)变更持续督导保荐代表人
近岸蛋白(688137)披露变更持续督导保荐代表人公告,4月20日股价上涨0.46%
证券之星 · 04-20
近岸蛋白(688137)披露变更持续督导保荐代表人公告,4月20日股价上涨0.46%
每周股票复盘:近岸蛋白(688137)拟注销257,986股回购股份
证券之星 · 04-19
每周股票复盘:近岸蛋白(688137)拟注销257,986股回购股份
近岸蛋白深陷困境:疫情红利褪去后,业绩股价“双杀”,三大隐忧浮出水面
新浪证券 · 04-17
近岸蛋白深陷困境:疫情红利褪去后,业绩股价“双杀”,三大隐忧浮出水面
暂无数据
公司概况
公司名称:
苏州近岸蛋白质科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-09-29
主营业务:
苏州近岸蛋白质科技股份有限公司的主营业务是靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产和销售及提供生物药、体外诊断、生命科学基础研究等领域的全流程应用解决方案。公司的主要产品是靶点及因子类蛋白、重组抗体、酶及试剂。公司获得了“CGT领域可靠原料与试剂供应启明星奖”、“CGT行业之星2025年度最优原材料提供商”等多项荣誉称号。
发行价格:
106.19
{"stockData":{"symbol":"688137","market":"SH","secType":"STK","nameCN":"近岸蛋白","latestPrice":37.27,"timestamp":1783580401000,"preClose":36.86,"halted":0,"volume":746702,"delay":0,"changeRate":0.0111,"floatShares":69917500,"shares":69917500,"eps":-1.0953,"marketStatus":"已收盘","change":0.41,"latestTime":"07-09 15:00:01","open":36.55,"high":37.99,"low":36.31,"amount":27625500,"amplitude":0.0456,"askPrice":37.27,"askSize":1,"bidPrice":37.12,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-1.0953,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783647000000},"marketStatusCode":5,"adr":0,"adjPreClose":36.86,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783560600000,1783567800000],[1783573200000,1783580400000]],"highLimit":40.55,"lowLimit":33.17,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":69917453,"isCdr":false,"pbRate":1.29,"roa":"--","roe":"--","epsLYR":-1.11,"committee":0.46988,"marketValue":2606000000,"turnoverRate":0.0107,"status":0,"afterMarket":{"amount":0,"volume":0,"close":37.27,"buyVolume":0,"sellVolume":0,"time":1783582437746,"indexStatus":"已收盘 07-09 15:30:00","preClose":36.86},"floatMarketCap":2606000000},"requestUrl":"/m/hq/s/688137/tweets","defaultTab":"tweets","newsList":[{"id":"2649692242","title":"每周股票复盘:近岸蛋白(688137)加码前沿研发平台建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692242","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649692242?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:25","pubTimestamp":1783196712,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,近岸蛋白报收于38.63元,较上周的33.67元上涨14.73%。本周,近岸蛋白7月2日盘中最高价报39.99元。6月29日盘中最低价报33.3元,股价触及近一年最低点。近岸蛋白当前最新总市值27.01亿元,在生物制品板块市值排名47/50,在两市A股市值排名4537/5203。报告期内公司持续在平台建设、未来业务布局以及原有产线提质增新上增加研发投入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562835","title":"股市必读:近岸蛋白(688137)6月30日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648562835?lang=zh_cn&edition=full","pubTime":"2026-07-01 04:38","pubTimestamp":1782851892,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,近岸蛋白报收于36.0元,下跌0.69%,换手率2.33%,成交量1.63万手,成交额5919.71万元。当日关注点交易信息汇总:6月30日主力资金净流入266.07万元,游资资金净流入573.0万元,散户资金净流出839.07万元。机构调研要点6月30日业绩说明会,网络互动问:2025年度公司增加了研发费用,主要是布局在哪些研发方向上?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100005799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646150443","title":"每周股票复盘:近岸蛋白(688137)完成股份回购并注销25.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646150443","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646150443?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:55","pubTimestamp":1782590110,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,近岸蛋白报收于33.67元,较上周的35.98元下跌6.42%。本周关注点公司公告汇总:近岸蛋白完成股份回购,实际回购257,986股,支付金额1,049.67万元。关于股份回购实施结果暨股份变动的公告苏州近岸蛋白质科技股份有限公司于2024年9月26日审议通过股份回购方案,拟以自有资金1,000万元至2,000万元通过集中竞价方式回购股份,用于减少注册资本。本次回购股份已于2026年6月24日注销,减少注册资本。注销后公司总股本相应减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800001246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645832067","title":"近岸蛋白(688137)披露股份回购实施结果暨股份变动公告,6月23日股价上涨4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645832067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645832067?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:36","pubTimestamp":1782225383,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘,近岸蛋白报收于36.8元,较前一交易日上涨4.13%,最新总市值为25.82亿元。近日,苏州近岸蛋白质科技股份有限公司披露《关于股份回购实施结果暨股份变动的公告》。公告显示,公司于2024年9月26日审议通过股份回购方案,拟以自有资金1,000万元至2,000万元通过集中竞价方式回购股份,用于减少注册资本。本次回购股份已于2026年6月24日注销,减少注册资本。注销后公司总股本相应减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638853532","title":"近岸蛋白(688137)披露2025年年度股东会决议公告,5月25日股价下跌3.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638853532","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638853532?lang=zh_cn&edition=full","pubTime":"2026-05-25 18:25","pubTimestamp":1779704719,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘,近岸蛋白报收于44.97元,较前一交易日下跌3.39%,最新总市值为31.56亿元。该股当日开盘46.57元,最高47.77元,最低44.38元,成交额达3073.36万元,换手率为0.97%。近日,苏州近岸蛋白质科技股份有限公司发布《2025年年度股东会决议公告》。所有议案均获通过,无否决议案。中小投资者对部分议案进行了单独计票,关联股东对相关议案回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637767643","title":"每周股票复盘:近岸蛋白(688137)2025年年度股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2637767643","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637767643?lang=zh_cn&edition=full","pubTime":"2026-05-24 05:23","pubTimestamp":1779571391,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,近岸蛋白报收于46.55元,较上周的48.28元下跌3.58%。本周关注点公司公告汇总:2025年年度股东会审议通过年度报告、利润分配预案等多项议案,出席股东所持表决权占69.2457%。国浩律师(上海)事务所就本次股东会的召集、召开程序、出席会议人员资格及表决程序出具法律意见书,确认会议召集、召开程序及表决结果合法有效。出席本次股东会的股东及代理人共40名,代表有表决权股份总数的69.2457%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636344064","title":"每周股票复盘:近岸蛋白(688137)2025年营收1.46亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636344064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636344064?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:06","pubTimestamp":1778958373,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,近岸蛋白报收于48.28元,较上周的49.38元下跌2.23%。本周,近岸蛋白5月12日盘中最高价报54.0元。2025年公司实现营业收入14,643.95万元,同比增长14.80%,归属于上市公司股东的净利润为-7,778.34万元。国联民生证券承销保荐有限公司作为公司首次公开发行股票并在科创板上市的保荐机构,持续督导期已于2025年12月31日届满,现发布持续督导保荐总结报告书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635370416","title":"5月15日近岸蛋白跌5.11%,国联医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635370416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635370416?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:29","pubTimestamp":1778833775,"startTime":"0","endTime":"0","summary":"证券之星消息,5月15日近岸蛋白跌5.11%,收盘报48.28元,换手率2.26%,成交量1.59万手,成交额7714.15万元。重仓近岸蛋白的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国联基金的国联医疗健康混合A。国联医疗健康混合A目前规模为0.12亿元,最新净值1.3828,较上一交易日下跌1.54%,近一年上涨19.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500029101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635713567","title":"近岸蛋白(688137)披露2025年年度股东会会议资料,5月14日股价下跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635713567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635713567?lang=zh_cn&edition=full","pubTime":"2026-05-14 17:59","pubTimestamp":1778752754,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘,近岸蛋白报收于50.88元,较前一交易日下跌0.78%,最新总市值为35.71亿元。该股当日开盘51.28元,最高52.0元,最低49.77元,成交额达5355.83万元,换手率为1.5%。近日,苏州近岸蛋白质科技股份有限公司发布2025年年度股东会会议资料。董事会报告指出,2025年公司实现营业收入14,643.95万元,同比增长14.80%,归属于上市公司股东的净利润为-7,778.34万元。全年召开7次董事会会议,审议35项议案,并完成股份回购404,337股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400034023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634592412","title":"每周股票复盘:近岸蛋白(688137)拟注销25.8万股回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2634592412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634592412?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:16","pubTimestamp":1778354170,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,近岸蛋白报收于49.38元,较上周的48.48元上涨1.86%。本周,近岸蛋白5月7日盘中最高价报51.88元。公司将注销回购股份中的257,986股,注册资本由70,175,439元减少至69,917,453元,总股本相应变更。本次股东会由董事会召集,董事长朱化星主持,采取现场与网络投票相结合方式召开,出席股东所持表决权占比69.2541%。议案属特别决议事项,获同意票占出席会议有效表决权的99.9851%,反对票占比0.0149%,无弃权票。中小股东同意该议案的比例为98.6307%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633103457","title":"近岸蛋白(688137)披露关于注销部分回购股份、减少注册资本及修订《公司章程》的议案,5月8日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633103457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633103457?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:32","pubTimestamp":1778250737,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,近岸蛋白报收于49.38元,较前一交易日下跌1.98%,最新总市值为34.65亿元。该股当日开盘50.76元,最高50.87元,最低49.38元,成交额达3738.45万元,换手率为1.07%。公告显示,公司于2026年5月8日召开2026年第一次临时股东会,审议通过《关于注销部分回购股份、减少注册资本及修订<公司章程>的议案》。议案为特别决议事项,获同意票数占出席会议有效表决权的99.9851%,反对票占比0.0149%,无弃权票。中小股东对该议案的同意票占比98.6307%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800043804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633116351","title":"5月7日近岸蛋白涨5.66%,国联医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633116351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633116351?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:31","pubTimestamp":1778142698,"startTime":"0","endTime":"0","summary":"证券之星消息,5月7日近岸蛋白涨5.66%创60日新高,收盘报50.38元,换手率2.16%,成交量1.51万手,成交额7634.45万元。重仓近岸蛋白的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国联基金的国联医疗健康混合A。国联医疗健康混合A目前规模为0.12亿元,最新净值1.3775,较上一交易日下跌1.09%,近一年上涨19.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700026645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623754","title":"每周股票复盘:近岸蛋白(688137)股东户数增31.06%,一季度营收增11.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623754","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632623754?lang=zh_cn&edition=full","pubTime":"2026-05-02 06:31","pubTimestamp":1777674671,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,近岸蛋白报收于48.48元,较上周的48.01元上涨0.98%。本周,近岸蛋白4月27日盘中最高价报50.0元。业绩披露要点:2026年一季度公司主营收入同比增长11.37%。公司公告汇总:拟注销已回购股份257,986股,减少注册资本。股本股东变化股东户数变动截至2026年3月31日,近岸蛋白股东户数为6734.0户,较2025年12月31日增加1596.0户,增幅达31.06%。户均持股数量由上期的1.37万股下降至1.04万股,户均持股市值为42.18万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631965135","title":"近岸蛋白(688137)3月31日股东户数0.67万户,较上期增加31.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631965135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631965135?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:42","pubTimestamp":1777455749,"startTime":"0","endTime":"0","summary":"证券之星消息,近日近岸蛋白披露,截至2026年3月31日公司股东户数为6734.0户,较12月31日增加1596.0户,增幅为31.06%。在生物制品行业个股中,近岸蛋白股东户数低于行业平均水平,截至3月31日,生物制品行业平均股东户数为3.56万户。从股价来看,2025年12月31日至2026年3月31日,近岸蛋白区间涨幅为1.07%,在此期间股东户数增加1596.0户,增幅为31.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631582344","title":"图解近岸蛋白年报:第四季度单季净利润同比下降35.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631582344","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631582344?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:13","pubTimestamp":1777396416,"startTime":"0","endTime":"0","summary":"证券之星消息,近岸蛋白2025年年报显示,当年度公司主营收入1.46亿元,同比上升14.8%;归母净利润-7778.34万元,同比下降42.94%;扣非净利润-7712.02万元,同比下降7.49%;其中2025年第四季度,公司单季度主营收入3458.46万元,同比下降2.51%;单季度归母净利润-4892.41万元,同比下降35.31%;单季度扣非净利润-4448.09万元,同比下降13.93%;负债率5.43%,投资收益26.75万元,财务费用-2776.37万元,毛利率67.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900003476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630398931","title":"近岸蛋白(688137)披露拟注销已回购股份暨减少注册资本公告,4月27日股价上涨1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630398931","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630398931?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:58","pubTimestamp":1777287508,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,近岸蛋白报收于48.77元,较前一交易日上涨1.58%,最新总市值为34.22亿元。该股当日开盘48.01元,最高50.0元,最低48.01元,成交额达2629.84万元,换手率为0.76%。公司于近日披露《2026年第一次临时股东会会议资料》公告。公告显示,苏州近岸蛋白质科技股份有限公司拟注销已回购的257,986股股份,减少注册资本,公司总股本将由70,175,439股变更为69,917,453元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630807085","title":"每周股票复盘:近岸蛋白(688137)变更持续督导保荐代表人","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807085?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:31","pubTimestamp":1777156267,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,近岸蛋白报收于48.01元,较上周的50.07元下跌4.11%。本周,近岸蛋白4月20日盘中最高价报50.79元。本周关注点公司公告汇总:因工作变动,近岸蛋白变更持续督导保荐代表人,由王嘉麟、阚绪兴接替王璐、陈卓履行相关职责。国联民生委派王嘉麟、阚绪兴接替其职务,继续履行募集资金未使用完毕相关的持续督导职责。持续督导期至中国证监会和上交所规定的义务结束为止。公司董事会对王璐、陈卓的贡献表示感谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600004006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628729768","title":"近岸蛋白(688137)披露变更持续督导保荐代表人公告,4月20日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628729768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628729768?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:17","pubTimestamp":1776694636,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘,近岸蛋白报收于50.3元,较前一交易日上涨0.46%,最新总市值为35.3亿元。近日,苏州近岸蛋白质科技股份有限公司披露《关于变更持续督导保荐代表人的公告》。持续督导期至中国证监会和上交所规定的义务结束为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000036764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628759681","title":"每周股票复盘:近岸蛋白(688137)拟注销257,986股回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2628759681","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628759681?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:38","pubTimestamp":1776537488,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,近岸蛋白报收于50.07元,较上周的43.68元上涨14.63%。本周,近岸蛋白4月15日盘中最高价报51.64元。本周关注点公司公告汇总:近岸蛋白拟注销已回购的257,986股股份,占总股本0.3676%。截至2026年4月13日,公司累计回购股份257,986股,占总股本的0.3676%,支付资金总额1,049.67万元,回购价格区间为37.93元/股至43.70元/股。公司拟申请注销已回购的全部股份,并已提请股东大会授权管理层办理后续减资及章程修订等事宜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628084152","title":"近岸蛋白深陷困境:疫情红利褪去后,业绩股价“双杀”,三大隐忧浮出水面","url":"https://stock-news.laohu8.com/highlight/detail?id=2628084152","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628084152?lang=zh_cn&edition=full","pubTime":"2026-04-17 19:02","pubTimestamp":1776423720,"startTime":"0","endTime":"0","summary":"昔日备受追捧的新冠概念股近岸蛋白,如今正经历业绩与估值的双重煎熬。公司日前披露的2025年业绩快报显示,去年归母净利润亏损7618万元,同比增亏40%,连续第二年陷入亏损。与此同时,公司股价较发行价破发幅度高达六成,上市三年有余,几乎全程“潜水”。 从业绩巅峰到深度亏损,近岸蛋白的坠落并非单纯的外部环境变化使然。在疫情红利消退的表象之下,公司自身在战略转型、核心竞争力及资金使用效率等方面的深层问题,正逐一暴露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-04-17/doc-inhuveqy6429586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688137","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783625854467,"stockEarnings":[{"period":"1week","weight":-0.0254},{"period":"1month","weight":-0.0256},{"period":"3month","weight":-0.1467},{"period":"6month","weight":-0.1316},{"period":"1year","weight":-0.0588},{"period":"ytd","weight":-0.0694}],"compareEarnings":[{"period":"1week","weight":0.0019},{"period":"1month","weight":0.0066},{"period":"3month","weight":0.0126},{"period":"6month","weight":-0.0203},{"period":"1year","weight":0.1556},{"period":"ytd","weight":0.0171}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州近岸蛋白质科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6734人(较上一季度增加31.06%)","perCapita":"10382股","listingDate":"2022-09-29","address":"江苏省苏州市吴江区吴江经济技术开发区云创路228号3层,4层","registeredCapital":"6991万元","survey":" 苏州近岸蛋白质科技股份有限公司的主营业务是靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产和销售及提供生物药、体外诊断、生命科学基础研究等领域的全流程应用解决方案。公司的主要产品是靶点及因子类蛋白、重组抗体、酶及试剂。公司获得了“CGT领域可靠原料与试剂供应启明星奖”、“CGT行业之星2025年度最优原材料提供商”等多项荣誉称号。","listedPrice":106.19},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"近岸蛋白,688137,近岸蛋白股票,近岸蛋白股票老虎,近岸蛋白股票老虎国际,近岸蛋白行情,近岸蛋白股票行情,近岸蛋白股价,近岸蛋白股市,近岸蛋白股票价格,近岸蛋白股票交易,近岸蛋白股票购买,近岸蛋白股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"近岸蛋白(688137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供近岸蛋白(688137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}